University Of Maryland, Baltimore
Clinical trials sponsored by University Of Maryland, Baltimore, explained in plain language.
-
Brain bleed drug combo study halted after just one patient
Disease control TerminatedThis study looked at whether adding the drug pioglitazone to a keyhole brain surgery (MIPS) could help people recover from a severe bleeding stroke. Only one person took part before the study was stopped early. The goal was to see if the combination was safe and helped clear the …
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 16, 2026 20:21 UTC
-
Cancer drug tested for COVID-19 falls short
Disease control TerminatedThis study tested whether imatinib, a cancer drug, could help hospitalized adults with COVID-19. The trial was stopped early after enrolling only 21 people. Researchers measured survival at 28 days and changes in patient health, but the small size limits what we can learn.
Phase: PHASE3 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Could freezing trauma patients save their lives?
Disease control TerminatedThis study tested a way to quickly cool down trauma patients whose hearts stopped from severe bleeding. The idea was to preserve the body long enough for surgeons to stop the bleeding, then slowly rewarm the patient using a heart-lung machine. The study involved 20 people and aim…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Can a common supplement repair diabetic nerve damage?
Disease control TerminatedThis early-phase study tested whether nicotinamide riboside (a form of vitamin B3) could help people with diabetic neuropathy, a condition causing nerve damage from diabetes. Ten adults with type 2 diabetes or prediabetes took the supplement for 6 months. Researchers measured cha…
Phase: PHASE1, PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
Gum treatment may shield aging brains from dementia
Prevention TerminatedThis study looked at whether intensive treatment for gum disease (periodontitis) could slow cognitive decline in older adults with mild memory problems and narrowed neck arteries. Researchers compared intensive gum therapy to standard care in 26 participants aged 65 and older. Th…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Prevention
Last updated Jun 15, 2026 19:08 UTC
-
Exercise and diet tested for chemo nerve damage
Symptom relief TerminatedThis study looked at whether exercise or nutrition education could reduce nerve pain caused by platinum chemotherapy in people with cancer. The trial aimed to enroll 36 adults scheduled for chemotherapy, but it was terminated early. The goal was to find better ways to manage this…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 15, 2026 19:02 UTC
-
Weight and breast cancer drugs: does size matter?
Knowledge-focused TerminatedThis study looked at whether postmenopausal women with higher body fat respond differently to standard doses of aromatase inhibitors (anastrozole or letrozole) compared to women with lower body fat. The goal was to see if weight affects how well these hormone-blocking pills shrin…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:54 UTC